Your browser doesn't support javascript.
loading
High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapy.
Yamada, Yunami; Fujii, Hironori; Ohata, Koichi; Kato-Hayashi, Hiroko; Watanabe, Daichi; Ishihara, Takuma; Uemura, Shinya; Iwashita, Takuji; Imai, Hisashi; Matsuhashi, Nobuhisa; Takahashi, Takao; Sugiyama, Tadashi; Shimizu, Masahito; Yoshida, Kazuhiro; Suzuki, Akio.
Afiliação
  • Yamada Y; Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
  • Fujii H; Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan. h_fujii@gifu-u.ac.jp.
  • Ohata K; Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
  • Kato-Hayashi H; Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
  • Watanabe D; Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
  • Ishihara T; Gifu University Hospital Innovative and Clinical Research Promotion Center Gifu University, Gifu, 501-1194, Japan.
  • Uemura S; First Department of Internal Medicine, Gifu University Hospital, Gifu, 501-1194, Japan.
  • Iwashita T; First Department of Internal Medicine, Gifu University Hospital, Gifu, 501-1194, Japan.
  • Imai H; Department of Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, 501-1193, Japan.
  • Matsuhashi N; Department of Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, 501-1193, Japan.
  • Takahashi T; Department of Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, 501-1193, Japan.
  • Sugiyama T; Laboratory of Pharmacy Practice and Social Science, Gifu Pharmaceutical University, Gifu, 501-1196, Japan.
  • Shimizu M; First Department of Internal Medicine, Gifu University Hospital, Gifu, 501-1194, Japan.
  • Yoshida K; Department of Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, 501-1193, Japan.
  • Suzuki A; Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
Med Oncol ; 36(7): 63, 2019 Jun 03.
Article em En | MEDLINE | ID: mdl-31161433
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bilirrubina / Protocolos de Quimioterapia Combinada Antineoplásica / Irinotecano / Neutropenia Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bilirrubina / Protocolos de Quimioterapia Combinada Antineoplásica / Irinotecano / Neutropenia Idioma: En Ano de publicação: 2019 Tipo de documento: Article